Skip to main content

Table 2 Spearman correlations between GLP-1, GIP, and selected variables in patients with MetS and pre-MetS conditions (n = 97).

From: Elevated circulating levels of an incretin hormone, glucagon-like peptide-1, are associated with metabolic components in high-risk patients with cardiovascular disease

 

GLP-1 r

P- value

GIP r

P- value

Age (years)

0.004

0.145

0.009

0.938

Sex

0.202

0.046

-0.063

0.603

Waist

0.078

0.464

0.274

0.310

BMI

0.089

0.747

0.486

0.056

LDL cholesterol (mg/dL)

0.204

0.093

0.357

0.003

HDL cholesterol (mg/dL)

-0.229

0.049

-0.009

0.941

Triglyceride (mg/dL)

0.243

0.023

0.041

0.730

Smoking

0.118

0.326

-0.133

0.274

CRP (μg/dL)

0.550

0.026

-0.047

0.694

Plasma glucose (mg/dL)

0.064

0.554

-0.388

0.140

Plasma insulin (IU/mL)

0.069

0.571

0.088

0.499

HOMA-IR

-0.116

0.284

0.013

0.920

Diabetes/IFG

0.049

0.652

-0.132

0.278

HbA1c

-0.303

0.212

-0.029

0.810

Hypertension

0.059

0.589

0.197

0.099

Dyslipidemia

0.031

0.773

0.011

0.925

Coronary artery disease

0.093

0.391

-0.094

0.439

Hyper uric acidemia

0.133

0.219

0.276

0.019

Serum uric acid (mg/dL)

0.245

0.025

-0.023

0.849

Fatty liver disease

-0.054

0.618

-0.115

0.340

Chronic kidney disease

0.029

0.793

-0.046

0.703

OSAS

0.178

0.099

-0.014

0.908

Metabolic score

0.470

<0.001

0.157

0.189

GIP (pg/mL)

0.383

<0.001

  
  1. GLP-1, glucagon-like peptide-1; GIP, gastric inhibitory polypeptide; r, Spearman correlation coefficients; BMI, body mass index; LDL, low density lipoprotein; HDL, high density lipoprotein; CRP, C-reactive protein; HOMA-IR, homeostatis model assessment; IFG, impaired fasting glucose; HbA1c, glycated haemoglobin; OSAS, obstructive sleep apnea syndrome.
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840